InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Fountain Nathan B, Director. Officer active across 1 companies, notably Acumen Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been recorded. Total volume traded: €169k. The latest transaction was disclosed on 6 July 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€84,5706,250 shares@ €13.53120.051% mcap100.0% of flow
Common Stock
SEC:0001209191-21-046026·
Ideal exit: 2 Apr 2022 (T+270)
€84,5706,250 shares@ €13.53120.051% mcap50.0% of flow
Common Stock
SEC:0001209191-21-046026:0·
Ideal exit: 2 Apr 2022 (T+270)
2 of 2 declarations
About Fountain Nathan B
Nathan B. Fountain is a Board Member at Acumen Pharmaceuticals, Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and the overall direction of the organization. His experience is valuable for Acumen.
